Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delgocitinib and Lidocaine on Pain and Itch Sensitivity in Healthy Volunteers
NCT07203274Not yet recruiting
- Sponsor
- Aalborg University
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of delgocitinib and lidocaine 10% oropharyngeal spray in pruritus, sponsored by Aalborg University. Primary endpoints: Itch by Visual Analog Scale at Day 2 and Superficial blood perfusion at Day 2. Planned start May 2026; status: not yet recruiting.
02
Drugs
delgocitiniblidocaine 10% oropharyngeal spray
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT07203274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07203274.